Share

cover art for Refugees, immigrant populations and substance use with Ebtesam Saleh

Addictions Edited

Refugees, immigrant populations and substance use with Ebtesam Saleh

Season 1, Ep. 22

In this episode, Rob Calder talks to the SSA's Fred Yates Prize winner Ebtesam Saleh. They discuss her work researching substance use among refugees and immigrant populations as well as her career going from a pharmacist in Yemen to becoming an award-winning researcher. This interview was conducted in September 2023 ahead of Ebtesam's Fred Yates Prize presentation and at the SSA's Annual Conference in Newcastle on 9 and 10 November 2023.


"Migrants lost their safe zone at the beginning. Completely. In terms of their land, their own families and loved ones. So they are struggling to start a new life but at the same time are living in a parallel world in their painful memories."


The opinions expressed in this podcast reflect the views of the author(s) and do not necessarily represent the opinions or official positions of the SSA.

The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.

More episodes

View all episodes

  • 5. Open Access publishing with Leila Moore

    14:22
    In this episode, Casy and Rob talk to Leila Moore, the Director of Open Access policy at Wiley. Leila covers the history, principles and processes relating to open access as well as describing the mechanisms by which research is made freely available for people who want to access it. Leila explains how open access publishing can increase accessibility and ensure research reaches a more diverse readership meaning that people who previously could not access research findings now can. Leila also explains APCs (article processing charges) and transformational agreements."Open access increases opportunities for collaboration reduces duplication, speeds up groundbreaking discoveries and enables more people than ever before to access this research. Whether that's a patient looking for information on illness, a teacher looking for new ways to work with students or a researcher who discovers the next great opportunity for collaboration."The opinions expressed in this podcast reflect the views of the author(s) and do not necessarily represent the opinions or official positions of the SSA.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.
  • 4. The impact factor with Thomas Broomfield

    30:06
    In this episode, Casy and Rob talk to Thomas Broomfield from Wiley about the impact factor. Thomas covers everything from how it is calculated, what it means, its limitations as well as discussing alternative ways to rate or assess a journal's output. Thomas covers hidden, linked and un-linked citations, describes how to get an impact factor of 254 and explains that sometimes people cite a journal cover image (whilst remaining uncertain about why).Thomas explains the JIF, the JCR, Web of Science, citation databases, DORA, ESCI, Clarivate, Alt Metrics and how they all relate to That Number. "The calculation itself has stayed pretty constant..... what has really changed is the underlying database, what's included, what isn't and what data is being used to make certain decisions."Thomas is a Senior Market Analyst at Wiley publishers. This conversation was recorded in February 2023.The opinions expressed in this podcast reflect the views of the author(s) and do not necessarily represent the opinions or official positions of the SSA.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.
  • 3. Choosing a journal with Prof. Bill Stoops

    14:14
    In this episode of Publishing Addiction Science, Dr Casy Calver talks to Prof. Bill Stoops about how to choose a journal in which to publish. Casy and Bill talk about how to define your audience so you can publish in a journal where your audience will find your research. Bill talks about his experiences as an author in addition to his views as a journal editor. He gives advice on how to approach journals to check whether an article is likely to be a good fit and therefore a good home for your hard won research paper. They also identify some red flags for identifying predatory journals.Professor Bill Stoops is Editor for the journal Experimental and Clinical Psychopharmacology. "One thing I really do think about... is where it's indexed. So, is it going to get caught in a broad search? Is it going to get caught in PubMed, is it going to get caught in PsychInfo?"The opinions expressed in this podcast reflect the views of the author(s) and do not necessarily represent the opinions or official positions of the SSA.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.
  • 2. Authorship decisions with Prof. Richard Pates

    11:01
    In this episode Dr Casy Calver talks to Professor Richard Pates, who is an ISAJE board member and Editor-in-Chief of the journal Substance Use.Richard talks about how to decide on journal manuscript authorship and the best time to discuss those roles in the writing process. Richard discusses some of the experiences he had as a junior researcher, and how they have informed his approach to authorship. He also covers his mentorship of early career researchers, and in his role as an editor of an academic journal."You've got to make a significant contribution, not because you're in a certain position or not because you're someone husband or wide, but because you've made a significant contribution to that paper"Richard is one of the founding members of ISAJE.The opinions expressed in this podcast reflect the views of the author(s) and do not necessarily represent the opinions or official positions of the SSA.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.
  • 1. Publishing Addiction Science - an introduction

    01:32
    Welcome to Publishing Addiction Science - a podcast for the perplexed. This series is for anyone working in addiction research who is trying to navigate the choppy waters of academic publishing. We will feature interviews with Editors-in-Chief of some of the leading academic addictions journals. They will tell you how to improve your chances of being published and how to avoid common errors.Dr Casy Calver is the Executive Officer of ISAJE, the International Society of Addiction Journal Editors, Editorial Director at the Grayken Center for Addiction at Boston Medical Center, and managing editor of the journal Addiction Science & Clinical Practice. Dr Rob Calder is Head of Communications and Operations at the SSA, the Society for the Study of Addiction. The opinions expressed in this podcast reflect the views of the author(s) and do not necessarily represent the opinions or official positions of ISAJE or the SSA.ISAJE and the SSA do not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.
  • 23. The SSA Annual Conference 2023

    14:56
    In this episode, Merve Mollaahmetoglu, Ben Scher, Zoe Swithenbank and Rob Calder talk live from the poster room (with mocktails) about their thoughts on day 1 of the SSA Annual Conference in 2023. They cover research into substance use among refugees, heroin assisted treatment, gambling research and ADHD and addiction.Apologies for a few sound quality issues in this episode.The opinions expressed in this podcast reflect the views of the presenters and interviewees and do not necessarily represent the opinions or official positions of the SSA.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.
  • 21. ADHD and addiction with Wim van den Brink

    32:14
    Professor Wim van den Brink will be giving the Society Lecture at the SSA's 2023 Annual Conference. In this special episode of the Addictions Edited podcast, he talks to Rob Calder about attention deficit hyperactivity disorder (ADHD) and addiction.“If we want to prevent substance use disorders in patients with ADHD, we have to start early.”In an exclusive interview for the Addictions Edited podcast, Wim says that he hopes to use his talk at the SSA conference to deliver a few key messages: firstly, that ADHD is very common in patients with addiction – perhaps one in four will have adult ADHD; secondly, that the overlap or comorbidity could be attributed to a number of things – from neurobiological and psychological factors, to genetics and the environment; and thirdly, that establishing the respective weight of these contributing factors is important for prevention and treatment – for example, in determining whether pharmacological treatments and neuromodulation could offer more promise than, say, psychotherapies.The opinions expressed in this post reflect the views of the author and do not necessarily represent the opinions or official positions of the SSA or the author’s academic institution.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.
  • 20. Prescribing and research consent for people who use benzodiazepines with Dr Karen Berry

    22:52
    In this podcast Rob Calder talks to Dr Karen Berry about the latest research in treatment for benzodiazepine use. They discuss the recent rise of illicit and prescribed benzodiazepines in recent years; the difference between prescribed and street drugs, and how drugs prescribed in the US are making their way onto illicit markets. “They've become a rising issue both as illicit benzos like etizolam...And then also people are using prescribed diazepam, but it's not prescribed to them. So they're able to get hold of proper diazepam but on the street.”Karen talks about her latest research project looking at prescribing regimes for people who want to address benzodiazepine use. She discusses why the team recruited people who use both benzodiazepines and opiates and the implications of their research for drug overdose deaths. Karen also talks about some of the issues raised by the project about gaining consent from participants and how that consent can change throughout an intervention and across different appointments and research team members. Dr Karen Berry is a research fellow at the University of Stirling employed by the Salvation Army Centre for Addiction and Substance Research.The opinions expressed in this podcast reflect the views of the guest(s) and do not necessarily represent the opinions or official positions of the SSA.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.